Radiation-induced signaling pathways that promote cancer cell survival (Review)
- Authors:
- Ashley L. Hein
- Michel M. Ouellette
- Ying Yan
-
Affiliations: Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA - Published online on: August 20, 2014 https://doi.org/10.3892/ijo.2014.2614
- Pages: 1813-1819
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Pignon JP, le Maitre A, Maillard E and Bourhis J: Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 92:4–14. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ramnath N, Dilling TJ, Harris LJ, et al: Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 143:eS314–eS340. 2013. View Article : Google Scholar | |
|
Wilkinson-Ryan I, Binder PS, Pourabolghasem S, et al: Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer. Gynecol Oncol. 134:24–28. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Johnstone RW, Ruefli AA and Lowe SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Milas L, Raju U, Liao Z and Ajani J: Targeting molecular determinants of tumor chemo-radioresistance. Semin Oncol. 32:S78–S81. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Bernier J: Current state-of-the-art for concurrent chemoradiation. Semin Radiat Oncol. 19:3–10. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ghiam AF, Spayne J and Lee J: Current challenges and future perspectives of radiotherapy for locally advanced breast cancer. Curr Opin Support Palliat Care. 8:46–52. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Gewirtz DA: Growth arrest and cell death in the breast tumor cell in response to ionizing radiation and chemotherapeutic agents which induce DNA damage. Breast Cancer Res Treat. 62:223–235. 2000. View Article : Google Scholar | |
|
Hawkins AJ, Golding SE, Khalil A and Valerie K: DNA double-strand break-induced pro-survival signaling. Radiother Oncol. 101:13–17. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Raleigh DR and Haas-Kogan DA: Molecular targets and mechanisms of radiosensitization using DNA damage response pathways. Future Oncol. 9:219–233. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Navolanic PM, Steelman LS and McCubrey JA: EGFR family signaling and its association with breast cancer development and resistance to chemotherapy (Review). Int J Oncol. 22:237–252. 2003.PubMed/NCBI | |
|
Linggi B and Carpenter G: ErbB receptors: new insights on mechanisms and biology. Trends Cell Biol. 16:649–656. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Arteaga Carlos L and Engelman Jeffrey A: ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell. 25:282–303. 2014.PubMed/NCBI | |
|
Rexer BN and Arteaga CL: Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications. Crit Rev Oncog. 17:1–16. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Valerie K, Yacoub A, Hagan MP, et al: Radiation-induced cell signaling: inside-out and outside-in. Mol Cancer Ther. 6:789–801. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Goldkorn T, Balaban N, Shannon M and Matsukuma K: EGF receptor phosphorylation is affected by ionizing radiation. Biochim Biophys Acta. 1358:289–299. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Lee H-C, An S, Lee H, et al: Activation of epidermal growth factor receptor and its downstream signaling pathway by nitric oxide in response to ionizing radiation. Mol Cancer Res. 6:996–1002. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kiyozuka M, Akimoto T, Fukutome M, Motegi A and Mitsuhashi N: Radiation-induced dimer formation of EGFR: implications for the radiosensitizing effect of cetuximab. Anticancer Res. 33:4337–4346. 2013.PubMed/NCBI | |
|
Yan Y, Hein AL, Greer PM, et al: A novel function of HER2/Neu in the activation of G2/M checkpoint in response to [gamma]-irradiation. Oncogene. June 9–2014.(Epub ahead of print). View Article : Google Scholar | |
|
Meng TC, Fukada T and Tonks NK: Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell. 9:387–399. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Leach JK, Van Tuyle G, Lin PS, Schmidt-Ullrich R and Mikkelsen RB: Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res. 61:3894–3901. 2001.PubMed/NCBI | |
|
Nyati MK, Maheshwari D, Hanasoge S, et al: Radiosensitization by Pan ErbB Inhibitor CI-1033 in vitro and in vivo. Clin Cancer Res. 10:691–700. 2004. View Article : Google Scholar | |
|
Liang K, Lu Y, Jin W, Ang KK, Milas L and Fan Z: Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther. 2:1113–1120. 2003.PubMed/NCBI | |
|
Geoerger B, Gaspar N, Opolon P, et al: EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts. Int J Cancer. 123:209–216. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Dittmann K, Mayer C, Fehrenbacher B, et al: Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem. 280:31182–31189. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Dittmann K, Mayer C and Rodemann HP: Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol. 76:157–161. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Dent P, Yacoub A, Fisher PB, Hagan MP and Grant S: MAPK pathways in radiation responses. Oncogene. 22:5885–5896. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Cui W, Yazlovitskaya EM, Mayo MS, Pelling JC and Persons DL: Cisplatin-induced response of c-jun N-terminal kinase 1 and extracellular signal-regulated protein kinases 1 and 2 in a series of cisplatin-resistant ovarian carcinoma cell lines. Mol Carcinog. 29:219–228. 2000. View Article : Google Scholar | |
|
Abbott DW and Holt JT: Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation. J Biol Chem. 274:2732–2742. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Tang D, Wu D, Hirao A, et al: ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J Biol Chem. 277:12710–12717. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Yan Y, Black CP and Cowan KH: Irradiation-induced G2/M checkpoint response requires ERK1/2 activation. Oncogene. 26:4689–4698. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Munshi A and Ramesh R: Mitogen-activated protein kinases and their role in radiation response. Genes Cancer. 4:401–408. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J and Rivard N: MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem. 79:355–369. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Aoudjit F and Vuori K: Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikis. J Cell Biol. 152:633–643. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Jost M, Huggett TM, Kari C, Boise LH and Rodeck U: Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway. J Biol Chem. 276:6320–6326. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Bonni A, Brunet A, West AE, Datta SR, Takasu MA and Greenberg ME: Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science. 286:1358–1362. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Clark CJ, McDade DM, O’Shaughnessy CT and Morris BJ: Contrasting roles of neuronal Msk1 and Rsk2 in Bad phosphorylation and feedback regulation of Erk signalling. J Neurochem. 102:1024–1034. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ewings KE, Hadfield-Moorhouse K, Wiggins CM, et al: ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-xL. EMBO J. 26:2856–2867. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Allan LA, Morrice N, Brady S, Magee G, Pathak S and Clarke PR: Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol. 5:647–654. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Tamamoto T, Ohnishi K, Takahashi A, et al: Correlation between gamma-ray-induced G2 arrest and radioresistance in two human cancer cells. Int J Radiat Oncol Biol Phys. 44:905–909. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Fritz G, Brachetti C and Kaina B: Lovastatin causes sensitization of HeLa cells to ionizing radiation-induced apoptosis by the abrogation of G2 blockage. Int J Radiat Biol. 79:601–610. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Yan Y, Black CP, Cao PT, et al: Gamma-irradiation-induced DNA damage checkpoint activation involves feedback regulation between extracellular signal-regulated kinase 1/2 and BRCA1. Cancer Res. 68:5113–5121. 2008. View Article : Google Scholar | |
|
Yacoub A, McKinstry R, Hinman D, Chung T, Dent P and Hagan MP: Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling. Radiat Res. 159:439–452. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Golding SE, Morgan RN, Adams BR, Hawkins AJ, Povirk LF and Valerie K: Pro-survival AKT and ERK signaling from EGFR and mutant EGFRvIII enhances DNA double-strand break repair in human glioma cells. Cancer Biol Ther. 8:730–738. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Wei F, Yan J, Tang D, et al: Inhibition of ERK activation enhances the repair of double-stranded breaks via non-homologous end joining by increasing DNA-PKcs activation. Biochim Biophys Acta. 1833.90–100. 2013.PubMed/NCBI | |
|
Cohen-Armon M: PARP-1 activation in the ERK signaling pathway. Trends Pharmacol Sci. 28:556–560. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Cohen-Armon M, Visochek L, Rozensal D, et al: DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol Cell. 25:297–308. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Golding SE, Rosenberg E, Neill S, Dent P, Povirk LF and Valerie K: Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response. Cancer Res. 67:1046–1053. 2007. View Article : Google Scholar | |
|
Yan Y, Greer PM, Cao PT, Kolb RH and Cowan KH: RAC1 GTPase plays an important role in gamma-irradiation induced G2/M checkpoint activation. Breast Cancer Res. 14:R602012. View Article : Google Scholar : PubMed/NCBI | |
|
Sasaoka T, Langlois WJ, Leitner JW, Draznin B and Olefsky JM: The signaling pathway coupling epidermal growth factor receptors to activation of p21ras. J Biol Chem. 269:32621–32625. 1994.PubMed/NCBI | |
|
Janes PW, Daly RJ, deFazio A and Sutherland RL: Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene. 9:3601–3608. 1994.PubMed/NCBI | |
|
Dent P, Reardon DB, Park JS, et al: Radiation-induced release of transforming growth factor alpha activates the epidermal growth factor receptor and mitogen-activated protein kinase pathway in carcinoma cells, leading to increased proliferation and protection from radiation-induced cell death. Mol Biol Cell. 10:2493–2506. 1999. | |
|
Hagan M, Wang L, Hanley JR, Park JS and Dent P: Ionizing radiation-induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells: MAP kinase inhibition enhances radiation-induced cell killing and G2/M-phase arrest. Radiat Res. 153:371–383. 2000. View Article : Google Scholar | |
|
Polivka J Jr and Janku F: Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther. 142:164–175. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yamaguchi H and Wang HG: The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene. 20:7779–7786. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Gardai SJ, Hildeman DA, Frankel SK, et al: Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem. 279:21085–21095. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Qi XJ, Wildey GM and Howe PH: Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function. J Biol Chem. 281:813–823. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Engström M, Karlsson R and Jönsson J-I: Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand. Exp Hematol. 31:316–323. 2003.PubMed/NCBI | |
|
Yang JY, Xia W and Hu MC: Ionizing radiation activates expression of FOXO3a, Fas ligand, and Bim, and induces cell apoptosis. Int J Oncol. 29:643–648. 2006.PubMed/NCBI | |
|
Obexer P, Geiger K, Ambros PF, Meister B and Ausserlechner MJ: FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death Differ. 14:534–547. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Jang S-W, Yang S-J, Srinivasan S and Ye K: Akt phosphorylates MstI and prevents its proteolytic activation, blocking FOXO3 phosphorylation and nuclear translocation. J Biol Chem. 282:30836–30844. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401:82–85. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Dan HC, Sun M, Kaneko S, et al: Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP). J Biol Chem. 279:5405–5412. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Shaw RJ and Cantley LC: Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 441:424–430. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Fumarola C, Bonelli MA, Petronini PG and Alfieri RR: Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer. Biochem Pharmacol. 90:197–207. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Fleckenstein K, Zgonjanin L, Chen L, et al: Temporal onset of hypoxia and oxidative stress after pulmonary irradiation. Int J Radiat Oncol Biol Phys. 68:196–204. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Sendoel A and Hengartner MO: Apoptotic cell death under hypoxia. Physiology. 29:168–176. 2014. View Article : Google Scholar | |
|
King TD, Bijur GN and Jope RS: Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium. Brain Res. 919:106–114. 2001. | |
|
Loberg RD, Vesely E and Brosius FC: Enhanced glycogen synthase kinase-3β activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J Biol Chem. 277:41667–41673. 2002. | |
|
Toulany M, Kehlbach R, Florczak U, et al: Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Ther. 7:1772–1781. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Soltoff SP, Carraway KL III, Prigent SA, Gullick WG and Cantley LC: ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Int J Radiat Biol. 14:3550–3558. 1994.PubMed/NCBI | |
|
Marone R, Cmiljanovic V, Giese B and Wymann MP: Targeting phosphoinositide 3-kinase - moving towards therapy. Biochim Biophys Acta. 1784:159–185. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Toulany M, Baumann M and Rodemann HP: Stimulated PI3K-AKT signaling mediated through ligand or radiation-induced EGFR depends indirectly, but not directly, on constitutive K-Ras activity. Mol Cancer Res. 5:863–872. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Minjgee M, Toulany M, Kehlbach R, Giehl K and Rodemann HP: K-RAS(V12) induces autocrine production of EGFR ligands and mediates radioresistance through EGFR-dependent Akt signaling and activation of DNA-PKcs. Int J Radiat Oncol Biol Phys. 81:1506–1514. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Toulany M, Lee K-J, Fattah KR, et al: Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair. Mol Cancer Res. 10:945–957. 2012. View Article : Google Scholar | |
|
Sahlberg SH, Gustafsson AS, Pendekanti PN, Glimelius B and Stenerlow B: The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines. Tumour Biol. 35:3525–3534. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Shimura T, Kakuda S, Ochiai Y, Kuwahara Y, Takai Y and Fukumoto M: Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 80:540–548. 2011. | |
|
Kim IA, Bae SS, Fernandes A, et al: Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines. Cancer Res. 65:7902–7910. 2005.PubMed/NCBI | |
|
Contessa JN, Hampton J, Lammering G, et al: Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells. Oncogene. 21:4032–4041. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304–6311. 1991.PubMed/NCBI | |
|
Shonai T, Adachi M, Sakata K, et al: MEK/ERK pathway protects ionizing radiation-induced loss of mitochondrial membrane potential and cell death in lymphocytic leukemia cells. Cell Death Differ. 9:963–971. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Lee YJ, Soh JW, Jeoung DI, et al: PKC epsilon-mediated ERK1/2 activation involved in radiation-induced cell death in NIH3T3 cells. Biochim Biophys Acta. 1593:219–229. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Dai X-F, Ding J, Zhang R-G, Ren J-H, Ma C-MC and Wu G: Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway. Int J Radiat Biol. 89:12013.PubMed/NCBI | |
|
Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K and Linn S: Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem. 73:39–85. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Smits VA and Medema RH: Checking out the G(2)/M transition. Biochim Biophys Acta. 1519:1–12. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
O’Connell MJ and Cimprich KA: G2 damage checkpoints: what is the turn-on? J Cell Sci. 118:1–6. 2005.PubMed/NCBI | |
|
Chen T, Stephens PA, Middleton FK and Curtin NJ: Targeting the S and G2 checkpoint to treat cancer. Drug Discov Today. 17:194–202. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kharbanda S, Saleem A, Datta R, Yuan ZM, Weichselbaum R and Kufe D: Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2. Cancer Res. 54:1412–1414. 1994.PubMed/NCBI | |
|
Rhind N, Furnari B and Russell P: Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast. Genes Dev. 11:504–511. 1997. View Article : Google Scholar | |
|
O’Connell MJ, Raleigh JM, Verkade HM and Nurse P: Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J. 16:545–554. 1997.PubMed/NCBI | |
|
Lundgren K, Walworth N, Booher R, Dembski M, Kirschner M and Beach D: mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell. 64:1111–1122. 1991. View Article : Google Scholar | |
|
Parker LL, Atherton-Fessler S and Piwnica-Worms H: p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15. Proc Natl Acad Sci USA. 89:2917–2921. 1992.PubMed/NCBI | |
|
Bulavin DV, Higashimoto Y, Demidenko ZN, et al: Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat Cell Biol. 5:545–551. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kastan MB and Bartek J: Cell-cycle checkpoints and cancer. Nature. 432:316–323. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Nikjoo H, O’Neill P, Wilson WE and Goodhead DT: Computational approach for determining the spectrum of DNA damage induced by ionizing radiation. Radiat Res. 156:577–583. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Yu H: Typical cell signaling response to ionizing radiation: DNA damage and extranuclear damage. Chin J Cancer Res. 24:83–89. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ward JF: DNA damage as the cause of ionizing radiation-induced gene activation. Radiat Res. 138:S85–S88. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Haddy N, Tartier L, Koscielny S, et al: Repair of ionizing radiation-induced DNA damage and risk of second cancer in childhood cancer survivors. Carcinogenesis. Apr 19–2014.Epub ahead of print. | |
|
Huhn D, Bolck HA and Sartori AA: Targeting DNA double-strand break signalling and repair: recent advances in cancer therapy. Swiss Med Wkly. 143:w138372013.PubMed/NCBI | |
|
Hosoya N and Miyagawa K: Targeting DNA damage response in cancer therapy. Cancer Sci. 105:370–388. 2014. View Article : Google Scholar | |
|
Iyama T and Wilson DM III: DNA repair mechanisms in dividing and non-dividing cells. DNA Repair. 12:620–636. 2013. View Article : Google Scholar : PubMed/NCBI |
